Hypoxia is a common stress to the foetus and results in increased cardiac vulnerability to adult ischaemic injury. This study tested the hypothesis that foetal hypoxia causes programming of increased AT 2 receptor (AT 2 R) expression in the heart, resulting in the heightened cardiac susceptibility to adult ischaemic injury.
Introduction
Epidemiological and animal studies have shown a clear association of adverse intrauterine environment with an increased risk of hypertension and ischaemic heart disease in the adulthood. 1 -4 Hypoxia is one of the most important and clinically relevant stresses that can adversely affect foetal development. There is clear evidence of a link between hypoxia and foetal intrauterine growth restriction and an increased risk of cardiovascular disease in offspring. 5 -13 Animal studies have demonstrated that foetal hypoxia causes a significant increase in the number and size of binucleated myocytes in the foetal heart, 14 resulting in the heightened heart susceptibility to acute ischaemia and reperfusion injury in adult male offspring in a sexdependent manner. 10,15 -17 Angiontensin II (Ang II) plays a fundamental role in the regulation of cardiovascular homeostasis, and it has been implicated in programming of cardiovascular disease induced by adverse in utero environment during the foetal development. 18 -22 Recent studies have demonstrated a link between foetal insults to differential epigenetic modifications of type 1 (AT 1 R) and type 2 (AT 2 R) Ang II receptor genes in the adrenal and kidney and the resultant alteration of their expression patterns in adult life, which may ultimately lead to the development of hypertension. 22 -24 However, the effect of foetal hypoxia on the ontogeny of Ang II receptors in the heart has not been determined. Both AT 1 R and AT 2 R are expressed in cardiac myocytes and have significant pathophysiological roles in heart diseases. 25 -29 Yet the effect of AT 1 R and AT 2 R on ischaemia and reperfusion injury in the heart remains controversial, depending on † These two authors contributed equally to the work.
systemic vs. local blockade, as well as chronic vs. acute blockade of AT 1 R and AT 2 R. Although long-term systemic administration of AT 1 R antagonists reduced ischaemic injury, 30 studies of the acute effects of AT 1 R and AT 2 R antagonists on the recovery of left ventricular function in the setting of ischaemia and reperfusion injury in isolated working rat hearts suggested a cardioprotective effect of AT 2 R blockade, but not AT 1 R blockade. 31, 32 The expression of both AT 1 R and AT 2 R is regulated by glucocorticoids. 25 It has been suggested that, in rats, glucocorticoids play an important role in foetal programming of AT 1 R and AT 2 R expression patterns in offspring. 33 The present study tests the hypothesis that foetal hypoxia causes programming of increased AT 2 R gene expression in the heart by down-regulating glucocorticoid receptors (GRs), which contributes to the increased ischaemic vulnerability of the heart in adult rats, resulting from foetal hypoxia.
Methods
An expanded Methods section is available in the Supplementary material online.
Experimental animals
Pregnant rats were randomly divided into two groups: (i) normoxic control (n ¼ 12), and (ii) hypoxic treatment of 10.5% O 2 from days 15 to 21 of gestation (n ¼ 12), as described previously. 17 Half of the normoxic and hypoxic animals were killed at day 21 of gestation and the foetuses were removed for the studies. The other half of pregnant rats were allowed to give birth and offspring were studied at 3 weeks and 3 months old. Each experimental group had five animals from different dams. Hearts were isolated from the 21-day foetuses, 3-week-old and 3-month-old offspring. For western immunoblots and DNA isolation, hearts were flash frozen in liquid N 2 and stored at 2808C until analysis. RNA was extracted immediately and stored at 2808C. For ex vivo studies, separate pregnant rats were used and hearts were isolated from day 17 foetal rats and cultured in M199 media at 378C in 95% air/5% CO 2 . 34 Previous work has demonstrated that the intact heart can survive and beat for at least 6 days in M199 media and up to 3 weeks within ideal conditions. 34, 35 These hearts in organ culture did not suffer from a loss of contractile function or any dedifferentiation. 35 After 24 h of recovery, hearts were treated with dexamethasone and/or RU 486 (GR antagonist) for 48 h in seven experimental groups: control, 0.01 mM, 0.1 mM, 1 mM dexamethasone treatments, 1 mM dexamethasone plus 0.1 mM or 1 mM RU 486 treatments, and 1 mM RU 486 alone. Each experimental group had six animals from different dams. All procedures and protocols were approved by the Institutional Animal Care and Use Committee, and followed the guidelines by US National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Western blot analysis
Protein was isolated from the hearts, and AT 1 R, AT 2 R, and GR protein abundance were measured with western blot analysis using the primary antibodies against AT 1 R (Santa Cruz Biotechnology, Santa Cruz, CA, USA; 1:100 dilution), AT 2 R (Santa Cruz; 1:200 dilution), and GR (Santa Cruz; 1:2000 dilution). Each experimental group had samples from five animals. To assure equal loading and minimize any confounding influence of variability among gels, an internal standard sample was loaded to each gel and band intensities were normalized to actin and the internal control.
Real-time RT-PCR
RNA was extracted from the hearts and mRNA abundance of AT 1a R, AT 1b R, and AT 2 R was determined by real-time RT -PCR.
Site-directed mutagenesis and reporter gene assay
Rat AT 2 R promoter sequence was obtained from rat genome data base (http://www.ncbi.nlm.nih.gov/mapview). Genomic DNA isolated from rat hearts was used as PCR template for DNA amplification. A 2130 bp fragment spanning 22080 bp to +49 bp relative to the transcriptional start site was amplified and cloned into pCR4-TOPO vector. The KpnI/XhoI fragment flanking the AT 2 R promoter region was then inserted into the luciferase reporter gene plasmid, pGL3 to yield the full-length promoter-reporter plasmid. Promoter analyses identified the presence of multiple glucocorticoid response elements (GREs). Site-specific deletions of GREs were constructed, respectively, and the reporter gene assay was performed using a rat embryonic heart-derived myogenic cell line H9c2, as described previously. 34 
Electrophoretic mobility shift assay (EMSA)
Nuclear extracts were collected from the hearts, and electrophoretic mobility shift assay (EMSA) was performed using the oligonucleotide probes of GREs at rat AT 2 R promoter region, as described previously. 34 
Hearts subjected to ischaemia and reperfusion
Hearts of 3-month-old offspring were isolated and retrogradely perfused via the aorta in a modified Langendorff apparatus, as previously described. 17 After the baseline recording, hearts were perfused for 5 min in the absence or presence of losartan (1 mM, a selective AT 1 R antagonist), or PD 123,319 (0.3 mM, a selective AT 2 R antagonist), or losartan plus PD 123,319, followed by subjection to 20 min of global ischaemia and 30 min of reperfusion, an approach used in many previous studies in a Langendorff preparation. 36 -38 Previous studies with prolonged reperfusion from 60 to 180 min showed that myocardial infarction and left ventricular recovery reached a plateau at approximately 30 min of reperfusion. 10, 38, 39 Each experimental group had hearts from five animals. Left ventricular developed pressure (LVDP), heart rate (HR), dP/dt max , dP/dt min , and LV end-diastolic pressure (LVEDP) were continuously recorded. Myocardial infarct size was measured at the end of reperfusion with 1% triphenyltetrazolium chloride, and was expressed as a percentage of the total left ventricular weight. Lactate dehydrogenase (LDH) activity was measured in coronary effluent collected at 30 s before the onset of ischaemia, and at 0, 1, 2, 3, 4, 5, 10, 15, 20, and 30 min of reperfusion, using TOX 7 assay kit from Sigma following the manufacture's instructions. The data were expressed as area under curve (AUC).
Statistical analysis
Data are expressed as mean + SEM. Statistical significance (P , 0.05) was determined by analysis of variance (ANOVA) followed by Neuman-Keuls post hoc testing or Student's t-test, where appropriate.
Results
3.1 Effect of development and foetal hypoxia on AT 1 R and AT 2 R protein and mRNA abundance in the heart
Protein and mRNA abundance of both AT 1 R and AT 2 R showed a development-dependent reduction in the heart, and no sex difference was observed ( Figure 1A and B). Whereas the expression levels in both 3-week-old and 3-month-old offspring were significantly decreased, when compared with those in the foetus, there were no significant differences in the expression levels between 3-week-old and 3-month-old offspring. In 3-month-old offspring, AT 2 R mRNA decreased to less abundance than that of AT 1a R and AT 1b R, resulting in a significant decrease in the AT 2 R/AT 1 R receptor ratio in the adult heart. Maternal hypoxia had no significant effect on the litter size (11.2 + 0.9 vs. 12.0 + 0.8). Previous studies in the same rat model showed that maternal hypoxia resulted in a decrease in birth weight, but had no significant effect on body weight of 3-month-old offspring. 10, 17 There was a significant decrease in protein abundance of AT 1 R, but not AT 2 R, resulting in an increased AT 2 R to AT 1 R ratio in hypoxic vs. control foetal hearts ( Figure 1C ). This was associated with a decrease in AT 1b R mRNA ( Figure 1D ). The same expression pattern persisted in the hearts of 3-week-old male offspring, whereas no significant differences in AT 1 R and AT 2 R were observed in females. In 3-month-old offspring, prenatal hypoxia increased protein ( Figure 1C ) and mRNA ( Figure 1D ) abundance of AT 2 R, but not AT 1 R, in the male heart. In females, both AT 1 R and AT 2 R were increased and the AT 2 R to AT 1 R ratio was not significantly changed ( Figure 1C) . Consistently, AT 1b R and AT 2 R mRNA abundance were significantly increased in the female heart ( Figure 1D ).
Inhibitory effect of GREs on the AT 2 R promoter activity
Rat AT 2 R promoter has a TATAA element at 246 from the transcription start site (see Supplementary material online, Figure S1 ). Deletion of the TATAA element significantly decreased the promoter activity ( Figure 2A) . Multiple GREs were identified at rat AT 2 R promoter. These include GRE1 (21853), GRE2 (21674), GRE3 (21526), GRE4 (21159), GRE5 (2945), GRE6 (2676), GRE7 (2107), and GRE8 (+13) (see Supplementary material online, Figure S1 ). Sitespecific deletion of each GRE independently caused a significant increase in the promoter activity ( Figure 2A ). While the GRE4 deletion stimulated the luciferse activity by 2.43-fold, deletion of other GREs increased the promoter activity by 1.5-to 1.9-fold.
Binding of GRs to the GREs at the AT 2 R promoter
Binding of nuclear proteins to the putative GREs at the AT 2 R promoter was evaluated by EMSA. Sequences of GRE oligos used in EMSA were presented in Supplementary material online, Figure S2 .
Immunoblot analysis confirmed the presence of GRs in the nuclear extracts used in EMSA ( Figure 2B , left panel). We first defined our criteria by analysing GRE6, as it was originally suggested at the AT 2 R promoter. 40 As shown in Figure 2B (right panel), incubation of nuclear extracts from rat hearts with double-stranded oligonucleotide probes of GRE6 resulted in a shift of DNA -protein complex, which was further supershifted by an anti-GR antibody. Extended studies showed identical electrophoretic mobility of protein-DNA complexes for GREs 1, 2, 3, 4, 5, 7, and 8 with that of GRE6 in EMSA, which were blocked by the cold competitions with homologous, heterologous (AT 1a R GRE), and the consensus GRE (CGRE) oligos (see Supplementary material online, Figure S2 ).
Dexamethasone inhibits AT 2 R expression in the heart
Dexamethasone treatment for 48 h produced a dose-dependent decrease in mRNA and protein abundance of AT 2 R in the intact foetal rat hearts (see Supplementary material online, Figure S3 ). RU 486 alone had no effect on AT 2 R mRNA but blocked the dexamethasone-induced reduction of AT 2 R mRNA abundance (see Supplementary material online, Figure S3 ). deletion of GREs and TATA were transiently co-transfected with pRL-SV40 driven R. reniformis luciferase in a rat embryonic heart-derived myogenic cell line H9c2. After 48 h, firefly and R. reniformis luciferase activities in cell extracts were measured using a dual-luciferase reporter assay system. The promoter activities were then calculated by normalizing the firefly luciferase activities to R. reniformis luciferase activity. Data are means + SEM. *P , 0.05 (one-way ANOVA), deletions vs. wild-type WTAT2R. n ¼ 6. (B) GR in nuclear extracts (NE) was demonstrated by western blot. Supershift with GR antibody (Ab) was used to identify protein shift at GRE6 binding site. r-hGR, human recombinant GR.
3.5 Effect of development and foetal hypoxia on GR abundance and GR binding to GREs at the AT 2 R promoter GR abundance in the heart was significantly increased in offspring when compared with the foetus ( Figure 3A) . However, the expression levels were not significantly different between 3-week-old and 3-month-old offspring. Additionally, no sex difference was observed ( Figure 3A) . Hypoxia decreased GR expression in the foetal heart, which was sustained in the hearts of both 3-week-old and 3-month-old offspring in a sex-independent manner ( Figure 3B ). Nuclear GR protein abundance was also decreased in 3-week-old and 3-month-old offspring ( Figure 3B ). In accordance, there were similar extent decreases in GR bindings to GREs 4, 6, 7, and 8 at the AT 2 R promoter in hearts of 3-month-old offspring ( Figure 4A ). The binding affinity of GR to GREs was determined in competition studies performed in pooled nuclear extracts from the hearts of adult offspring with the increasing ratio of unlabelled/labelled oligonucleotides encompassing the GRE4 at 21159 in the AT 2 R promoter. Foetal hypoxia had no significant effect on the binding affinity of nuclear extracts to the GRE in the hearts of both male and female adult rats ( Figure 4B ).
Functional role of AT 2 R in acute ischaemia and reperfusion injury
The functional significance of AT 2 R in modulating the postischaemic recovery of left ventricle (LV) function after acute ischaemia was determined in a Langendorff preparation using a selective AT 2 R inhibitor, PD 123,319. As shown in Supplementary material online, Table S1 , there were no significant differences in LVDP, HR, dP/dt max , dP/dt min , and coronary flow rate at the baseline among all groups. PD 123,319 significantly improved the postischaemic recovery of LVDP ( Figure 5A and B), as well as dP/dt max and dP/dt min (see Supplementary material online, Figure S4 ) in both male and female hearts. Consistently, PD 123,319 decreased LVEDP (see Supplementary material online, Figure S4 ), myocardial infarct size, and LDH release ( Figure 5C and D) after myocardial ischaemia in both male and female animals. In contrast, an AT 1 R selective inhibitor losartan impaired the postischaemic recovery of LVDP ( Figure 5A and B) and dP/dt max and dP/dt min (see Supplementary material online, Figure S4 ), and significantly increased LVEDP (see Supplementary material online, Figure S4 ), myocardial infarct size, and LDH release ( Figure 5C and D) . In the presence of both PD 123,319 and losartan, there were no significant differences in the postischaemic recovery of LV function and myocardial infarction ( Figure 5 ; see Supplementary material online, Figure S4 ). The recovery of HR and coronary flow rate was not significantly different among all groups (data not shown).
Inhibition of AT 2 R restores foetal hypoxia-induced cardiac vulnerability to ischaemic injury in offspring
To determine whether increased AT 2 R in the heart is an important factor in the foetal hypoxia-induced increase in cardiac ischaemic susceptibility in adult male offspring, additional studies were performed in the hearts of adult offspring that had been exposed to hypoxia before birth. In the absence of PD 123,319, foetal hypoxia was associated with a significant decrease in postischaemic recovery of LVDP and increases in LVEDP, infarct size, and LDH release ( Figure 6 ), as well as decreases in the recovery of dP/dt max and dP/dt min (see Supplementary material online, Figure S5 ), as previously reported. 17 PD 123,319 increased postischaemic recovery of left ventricular function and abolished the difference in ischaemic injury observed between the control and hypoxic rats ( Figure 6 and see Supplementary material online, Figure S5 ).
Discussion
The present study demonstrates for the first time that foetal hypoxia results in programming of differential expression patterns of angiotensin II receptors in the heart of offspring. Whereas maternal hypoxia had no effect on the litter size, it decreased the birth weight, which could contribute to the changes observed. The finding that prenatal hypoxia increased AT 2 R expression in adult hearts is intriguing and suggests epigenetic reprogramming of a foetal gene of pathophysiological significance in the heart in a developmental-dependent manner. Consistent with the previous studies, 40 -42 we identified the TATAA box region at the AT 2 R promoter, which plays a critical role in the transcription of AT 2 R gene in rat hearts. The sequences of multiple GREs identified at rat AT 2 R gene promoter are imperfect representation (half sites) of the positive regulatory CGRE sequence, 5 ′ -GGTACAnnnTGTTCT-3 ′ . 43 The finding of the inhibitory effects of these GREs on the AT 2 R promoter activity suggests a novel mechanism of glucocorticoids in regulating the ontogeny of cardiac AT 2 R gene expression patterns during the development. Normal foetal adrenal produces low levels of glucocorticoids. Among other functions, the low foetal glucocorticoid levels may contribute to maintaining the relatively high levels of AT 2 R in foetal tissues, whereas the substantial increases in circulating glucocorticoid levels and GR abundance in the heart during the postnatal development are likely to play a key role in down-regulating AT 2 R in the adult in a tissue-specific manner. This is supported by the finding that dexamethasone caused a dose-dependent decrease in AT 2 R protein and mRNA expression in the heart, which was inhibited by RU486, indicating a GR-mediated response. The finding that foetal hypoxia caused significant decreases in both total and nuclear GR protein abundance in the heart of offspring provides a mechanism that may contribute to the partial reversal of glucocorticoid-dependent downregulation of AT 2 R, resulting in the increased AT 2 R expression in the heart. Indeed, foetal hypoxia resulted in about a 50% decrease in GR binding to the GREs at the Figure 6 Rescue effect of PD123,319 on hypoxia-mediated ischaemic vulnerability. Hearts were isolated from 3-month-old male offspring that had been exposed to normoxia (control) or hypoxia before birth, and were treated in the absence or presence of PD123,319 (0.3 mM) for 5 min before subjecting to 20 min of ischaemia and 30 min of reperfusion in a Langendorff preparation. Post-ischaemic recovery of LVDP, end-diastolic pressure (LVEDP), and infarct size were determined. LDH release over 30 min of reperfusion was measured as AUC. Data are means + SEM. Data were analysed by two-way ANOVA. *P , 0.05, hypoxia vs. control; † P , 0.05, +PD123,319 vs. 2PD123,319. n ¼ 5.
AT 2 R promoter in adult hearts, which were similar to the extent of decreased nuclear GR protein abundance. The finding that the binding affinity of nuclear extracts to the GREs in the hearts was not significantly different between control and foetal hypoxic animals suggests that the decreased GR binding to the GREs at rat AT 2 R promoter is mainly mediated by the reduced GR density. In the present study, the foetal origin of hypoxia-mediated repression of GR expression was demonstrated in the foetal heart. The sustained downregulation of GR density in adult hearts suggests an epigenetic modification of GR gene repression, albeit the mechanisms are not known at present. The inert response of AT 2 R expression to hypoxia in the foetal heart is possibly due to the low glucocorticoid levels in the foetus.
To less extent, AT 1b R gene is also negatively regulated by glucocorticoids. 44 Unlike in rodents, in large mammals including humans there is only one type of AT 1 R. In contrast, both humans and rodents have one type of AT 2 R. Because there is no human equivalent to the rodent AT 1b R, it may be difficult to translate the present findings directly into the humans. Nonetheless, although the expression of AT 1a R and AT 1b R genes in rodents are under different promoter controls, they are functionally and pharmacologically indistinguishable at the protein level. In the present study, the increased AT 1 R protein abundance in the heart of female adult offspring by foetal hypoxia is mainly mediated by the upregulation of AT 1b R gene expression. Although the cause of the gender difference in programming of AT 1 R expression patterns in the heart remains unclear, it has been shown in rats that foetal corticosterone exposure results in increased AT 2 R in the kidney of both male and female offspring, but increased AT 1 R only in females. 24 In the presents study, the increased AT 1 R in hearts of the hypoxic females is likely to balance the elevated AT 2 R and thus protects the female hearts from the heightened ischaemic injury resulting from prenatal hypoxia. The finding that foetal hypoxia induced changes in AT 1 R and AT 2 R expression patterns in the heart of offspring suggest a possible pathophysiological consequence. 25, 45 Indeed, our previous studies in the same animal model demonstrated that foetal hypoxia caused an increase in heart susceptibility to ischaemia and reperfusion injury in male offspring in a sex-dependent manner. 17 It has been well accepted that long-term, systemic administration of AT 1 R blockers prevents the deleterious consequences of ischaemia and reperfusion injury and reduces cardiac remodelling. The function that AT 2 R plays in normal or diseased hearts is much less clear and appears controversial. 46 -48 The effects of long-term and systemic blockade of AT 1 R or AT 2 R (as well as receptor knockout studies) on the heart involve multiple mechanisms, whereas the acute and direct effects of AT 1 R and AT 2 R on modulating ischaemia and reperfusion injury may be quite different as those seen in the long-term and systemic effects. Indeed, the present study demonstrates a novel direct cardioprotective effect of AT 1 R and the opposite effect of AT 2 R in acute ischaemia reperfusion injury in a gender-independent manner. Given the finding that the coronary flow rate was not altered, the effects are mainly mediated by myocardial cell responses. Furthermore, the finding of the lack of effect with the combination of both AT 1 R and AT 2 R blockade indicates an interaction between AT 1 R and AT 2 R in the heart, and suggests that the ratio of AT 2 R to AT 1 R is an especially important consideration in the cardiac susceptibility to acute ischaemia and reperfusion injury. Supporting this notion, it has been proposed that the pathophysiological function of AT 2 R is context-specific, i.e. the ratio of AT 2 R to AT 1 R. 49 The increased ratio of AT 2 R to AT 1 R in the heart of adult male offspring demonstrated in the present study is likely to play a key role in the heightened heart susceptibility to acute ischaemia and reperfusion injury in adult male offspring that had been exposed to hypoxia before birth. This is supported by the finding that the blockade of AT 2 R with PD 123,319 rescued the myocardial phenotype of the increased ischaemic susceptibility in male offspring after prenatal hypoxic exposure, providing the cause-and-effect evidence for the role of increased AT 2 R in foetal programming of enhanced cardiac vulnerability to acute ischaemic injury. Future studies of developmental overexpression of AT 2 R in the heart are needed to determine whether the increased AT 2 R mimics and is sufficient for the hypoxic response. Whereas the mechanisms underlying the different effects of AT 1 R and AT 2 R in acute cardiac ischaemic injury remain unclear, it has been known that AT 1 R promotes cell growth and proliferation, yet AT 2 R mediates antigrowth and apoptosis. 25, 50 These apparent opposite effects provide a congruent functional basis for understanding the different effects of AT 1 R and AT 2 R in modulating acute cardiac ischaemic injury vs. long-term cardiac remodelling. Our previous study suggested that downregulation of PKC1 in the heart played a role in the increased ischaemic susceptibility in adult male offspring resulting from prenatal hypoxia. 17 Given that AT 1 R stimulation and AT 2 R blockade activate PKC1 and mimic ischaemic preconditioning by reducing infarct size, 51 -53 it is possible that foetal hypoxia-induced programming of increased AT 2 R/AT 1 R ratio in the heart of adult males suppresses the PKC1 activity, leading to the enhanced susceptibility to ischaemic injury. The present investigation provides novel evidence of foetal programming of upregulation of the AT 2 R/AT 1 R ratio in the heart of adult males, linking foetal hypoxia and the increased susceptibility to ischaemia and reperfusion injury in the heart of adult male offspring in a sex-dependent manner. Given that hypoxia is one of the most important and clinically relevant stresses to the foetus, and that large epidemiological studies indicate a link between in utero adverse stimuli during gestation and an increased risk of ischaemic heart disease in the adulthood, the present study provides a mechanistic understanding worthy of investigation in humans.
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